Jacobs Levy Equity Management Inc. Sells 283,754 Shares of Seer, Inc. (NASDAQ:SEER)

Jacobs Levy Equity Management Inc. lessened its holdings in Seer, Inc. (NASDAQ:SEER - Free Report) by 63.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 161,864 shares of the company's stock after selling 283,754 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.27% of Seer worth $374,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Renaissance Technologies LLC raised its position in Seer by 27.0% in the fourth quarter. Renaissance Technologies LLC now owns 843,700 shares of the company's stock worth $1,949,000 after purchasing an additional 179,568 shares in the last quarter. Bridgeway Capital Management LLC grew its stake in Seer by 17.6% during the fourth quarter. Bridgeway Capital Management LLC now owns 727,743 shares of the company's stock worth $1,681,000 after buying an additional 109,000 shares during the last quarter. D. E. Shaw & Co. Inc. grew its stake in Seer by 16.8% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 719,901 shares of the company's stock worth $1,663,000 after buying an additional 103,630 shares during the last quarter. Peapod Lane Capital LLC bought a new stake in Seer during the fourth quarter worth about $991,000. Finally, JPMorgan Chase & Co. grew its stake in Seer by 67.5% during the third quarter. JPMorgan Chase & Co. now owns 175,354 shares of the company's stock worth $345,000 after buying an additional 70,671 shares during the last quarter. Institutional investors and hedge funds own 75.20% of the company's stock.

Seer Stock Performance

Seer stock traded up $0.02 during trading hours on Friday, hitting $2.10. 154,694 shares of the stock were exchanged, compared to its average volume of 328,707. The stock has a market capitalization of $125.54 million, a P/E ratio of -1.62 and a beta of 1.58. Seer, Inc. has a 12 month low of $1.56 and a 12 month high of $2.63. The business's 50-day moving average is $1.93 and its two-hundred day moving average is $2.17.

Seer (NASDAQ:SEER - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.03. The firm had revenue of $4.21 million for the quarter, compared to analysts' expectations of $3.25 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. On average, equities analysts predict that Seer, Inc. will post -1.42 earnings per share for the current fiscal year.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.